Flash e-reader

 Go to e-reader chapter








Table 14.4

Recipient De Novo Posttransplant Lymphoproliferative Disorders (PTLD), 2000 to 2009

by Transplant Type

Organ Type Year of Transplant
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
Total Total Recipients 23,281 24,260 24,921 25,486 27,053 28,117 28,942 28,372 27,966 28,465
# With PTLD (1) 321 332 330 291 267 257 212 202 151 108
% With PTLD (1) 1.4% 1.4% 1.3% 1.1% 1.0% 0.9% 0.7% 0.7% 0.5% 0.4%
Heart-Lung Total Recipients 48 27 33 29 40 35 31 31 27 29
# With PTLD (1) 4 2 2 3 1 - - - - -
% With PTLD (1) 8.3% 7.4% 6.1% 10.3% 2.5% - - - - -
Heart Total Recipients 2,199 2,202 2,155 2,057 2,015 2,125 2,193 2,209 2,163 2,212
# With PTLD (1) 51 51 38 42 28 31 15 11 15 3
% With PTLD (1) 2.3% 2.3% 1.8% 2.0% 1.4% 1.5% 0.7% 0.5% 0.7% 0.1%
Intestine Total Recipients 82 113 107 116 152 178 175 198 185 180
# With PTLD (1) 6 9 8 11 11 9 12 15 11 12
% With PTLD (1) 7.3% 8.0% 7.5% 9.5% 7.2% 5.1% 6.9% 7.6% 5.9% 6.7%
Kidney Total Recipients 13,620 14,276 14,779 15,137 16,006 16,483 17,095 16,634 16,521 16,830
# With PTLD (1) 124 144 147 131 114 112 76 82 49 27
% With PTLD (1) 0.9% 1.0% 1.0% 0.9% 0.7% 0.7% 0.4% 0.5% 0.3% 0.2%
Kidney-Pancreas Total Recipients 915 891 906 871 881 903 924 864 837 854
# With PTLD (1) 11 11 9 5 7 8 10 2 7 3
% With PTLD (1) 1.2% 1.2% 1.0% 0.6% 0.8% 0.9% 1.1% 0.2% 0.8% 0.4%
Liver Total Recipients 5,001 5,195 5,332 5,673 6,171 6,444 6,651 6,494 6,319 6,320
# With PTLD (1) 90 67 87 64 72 61 67 62 51 38
% With PTLD (1) 1.8% 1.3% 1.6% 1.1% 1.2% 0.9% 1.0% 1.0% 0.8% 0.6%
Lung Total Recipients 977 1,083 1,054 1,099 1,185 1,407 1,406 1,471 1,478 1,661
# With PTLD (1) 31 37 27 29 24 28 22 21 10 16
% With PTLD (1) 3.2% 3.4% 2.6% 2.6% 2.0% 2.0% 1.6% 1.4% 0.7% 1.0%
Pancreas After Kidney Total Recipients 305 305 375 344 420 343 293 261 213 198
# With PTLD (1) 2 5 7 3 4 3 3 2 - -
% With PTLD (1) 0.7% 1.6% 1.9% 0.9% 1.0% 0.9% 1.0% 0.8% - -
Pancreas Transplant Alone Total Recipients 134 168 180 160 183 199 174 210 223 181
# With PTLD (1) 2 6 5 3 6 5 7 7 8 9
% With PTLD (1) 1.5% 3.6% 2.8% 1.9% 3.3% 2.5% 4.0% 3.3% 3.6% 5.0%


Source: OPTN/SRTR Data as of October 1, 2010.

(-) = None in category.

(1) PTLD: Posttransplant Lymphoproliferative Disorders.

Year indicates the year of transplant, not the year of cancer diagnosis. Includes both deceased and living donor transplants.

Percent decreases in later years because of limited follow-up.

Recipient malignancy statistics are based on voluntary reporting to the OPTN.